Cefozopran
Jump to navigation
Jump to search
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
ECHA InfoCard | 100.107.680 |
Chemical and physical data | |
Formula | C19H17N9O5S2 |
Molar mass | 515.52 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Cefozopran (INN) is a fourth-generation cephalosporin.[1]
Spectrum of bacterial susceptibility and resistance
Most of the strains of Stenotrophomonas maltophilia have developed resistance toward cefozopran.[2]
References
- ^ Chang XM (December 1996). "Chapter 34: Market to Market". In Bristol JA (ed.). Annual Reports in Medicinal Chemistry. Vol. 31. San Diego, Calif.: Academic Press. p. 339. ISBN 978-0-08-058375-4.
- ^ "Cefozopran Susceptibility and Resistance Data" (PDF). Retrieved 23 July 2013.
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Cephalosporin antibiotics
- Thiadiazoles
- Ketoximes
- All stub articles
- Antibiotic stubs